EDGAR Filing Documents for 0001104659-15-052162

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001104659-15-052162

Filing Date

2015-07-21

Accepted

2015-07-21 16:02:09

Documents

Period of Report

2015-07-17

Document Format Files

Seq	Description	Document	Type	Size
1	4	a4.html	4
1	4	a4.xml	4	4001
	Complete submission text file	0001104659-15-052162.txt		5436

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971

CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ., BLDG. 1400E, STE.B14202 CAMBRIDGE MA 02139

Business Address

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 15997912